Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug surveillance: concepts, objectives, and methods].

R C Susano1, L Laborinho Fialho, J F de Quirós

  • 1A.R.S. de Leiria, Portugal.

Acta Medica Portuguesa
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment with chemotherapy of scleredema associated with Ig A myeloma.

International journal of dermatology·2001
Same author

Cutaneous ulcerations in a patient with rheumatoid arthritis receiving treatment with methotrexate.

The Journal of rheumatology·2000
Same author

[The treatment of human fascioliasis with triclabendazole].

Revista clinica espanola·1999
Same author

Autoimmune hemolytic anemia associated with eosinophilic fasciitis.

The Journal of rheumatology·1998
Same author

[Mesenteric lymph node cavitation: a rare complication of celiac disease in the adult].

Gastroenterologia y hepatologia·1998
Same author

Immune complex-mediated haemolytic anaemia and Evans syndrome induced by diclofenac.

Vox sanguinis·1997

Adverse drug reactions are a significant clinical challenge, often difficult to definitively link to specific medications. This review covers drug surveillance programs, their methods, and the situation in EEC countries.

Area of Science:

  • Pharmacovigilance and clinical pharmacology.
  • Drug safety and regulatory science.

Context:

  • Adverse drug reactions (ADRs) pose a significant challenge in clinical practice due to their frequency and morbidity.
  • Establishing a definitive causal link between a drug and observed clinical or laboratory findings is often difficult.
  • Limited physician sensitivity to ADRs further complicates accurate diagnosis and reporting.

Purpose:

  • To review the fundamental concepts, objectives, and methodologies of drug surveillance programs.
  • To provide an overview of the current state of drug surveillance within European Economic Community (EEC) countries.

Summary:

  • The paper discusses the complexities in identifying ADRs, including methodological challenges and physician awareness.
  • It details the principles and goals of pharmacovigilance systems.

Related Experiment Videos

  • An examination of drug surveillance practices in EEC nations is presented.

    • Impact:

    • Highlights the importance of robust drug surveillance for patient safety.
    • Aims to improve the understanding and implementation of pharmacovigilance strategies.
    • Provides insights into the regulatory landscape of drug safety in Europe.